Strategic Research Sponsor of the American Bar Association's Section of International Law
Tripp Haston
Office:
One Federal Place
1819 Fifth Avenue North
35203
City:
Birmingham
State:
Alabama
Country:
USA
Tel:
+1 205 521 8303
Fax:
+1 205 488 6303

Questions and Answers:

Who's Who Legal Thought Leaders: Life Sciences

Tripp Haston co-chairs Bradley’s life sciences industry team. He represents a broad spectrum of clients as trial and coordinating counsel, as well as a team member in individual actions and mass tort and multi-district litigation. He has been recognised in numerous leading attorney directories including The Best Lawyers in America, Chambers USA and Who’s Who Legal: Product Liability Defence. His experience has involved matters throughout the United States, Europe, Asia and South America.

WHAT ATTRACTED YOU TO THE LIFE SCIENCES SECTOR? 

Kismet. 16 ago, a global life sciences client deeply involved me in a high-stakes international mass tort. Since that time, I have been fortunate enough to serve several other global clients with similar challenges. I thoroughly enjoy the ongoing learning process required to stay sharp with life sciences clients.

HOW DOES YOUR PRACTICE STAND OUT FROM OTHER COMPETITORS IN THE MARKET? 

Value. My broad experience – regionally, nationally and globally – for domestic-based and foreign-based clients is rare for a person my age, particularly one whose base is not in a major and more costly legal market.

MEDICATIONS ON THE MARKET ARE BECOMING MORE PRECISE DUE IN PART TO ADVANCEMENTS IN DNA RESEARCH. HOW DO YOU THINK THE INCREASE OF MORE EFFECTIVE MEDICATIONS WILL IMPACT LITIGATION? 

Positively. Improvements in life sciences products will expand efficacy and reduce risk in their use. This will have positive effects in public health and secondarily likely reduce the extent of life sciences-related litigation.

AS THIRD-PARTY FUNDING BECOMES MORE OF AN INDUSTRY NORM, WHAT EFFECTS DO YOU THINK THIS WILL HAVE ON THE LIFE SCIENCES SECTOR? 

Extensive. Funding will result in more litigation generally, and more spurious claims in particular. Sooner rather than later, funders will be subject to certain disclosure and oversight regulation, which could bring greater transparency to this opaque and mysterious market. 

WHAT IS THE GREATEST CHALLENGE CURRENTLY FACING PRACTITIONERS IN THE LIFE SCIENCES SECTOR? 

Relevance. All lawyers, regardless of sector, must strive to stay relevant and valuable to their clients. This is especially true with the advent of legal AI and other technologies that make delivery of legal services more efficient for clients.

THERE HAS BEEN A NOTABLE RISE IN THE NUMBER OF CONSOLIDATED PROCEEDINGS IN THE US. HAS THIS AFFECTED YOUR PRACTICE? 

Definitely. Federal multi-district litigations and consolidated state proceedings have trended up significantly for the past several years. I’ve been privileged to lead trial and coordination efforts in defence of these types of proceedings for numerous clients.

HOW DO YOU PLAN TO DEVELOP YOUR PRACTICE IN THE FUTURE? 

Globally. As the global economy becomes more interconnected, I expect my experience managing and eliminating risk for clients will continue to evolve to meet the needs of domestic-based and foreign-based clients. This is particularly true for Asian clients with less experience with US-style litigation.

Who's Who Legal Thought Leaders: Product Liability Defence

Tripp Haston co-chairs Bradley’s life sciences industry team. He represents a broad spectrum of clients as trial and coordinating counsel, as well as a team member in individual actions and mass tort and multi-district litigation. He has been recognised in numerous leading attorney directories including The Best Lawyers in America, Chambers USA and Who’s Who Legal: Product Liability Defence. His experience has involved matters throughout the United States, Europe, Asia and South America.

WHAT ATTRACTED YOU TO THE LIFE SCIENCES SECTOR? 

Kismet. 16 ago, a global life sciences client deeply involved me in a high-stakes international mass tort. Since that time, I have been fortunate enough to serve several other global clients with similar challenges. I thoroughly enjoy the ongoing learning process required to stay sharp with life sciences clients.

HOW DOES YOUR PRACTICE STAND OUT FROM OTHER COMPETITORS IN THE MARKET? 

Value. My broad experience – regionally, nationally and globally – for domestic-based and foreign-based clients is rare for a person my age, particularly one whose base is not in a major and more costly legal market.

MEDICATIONS ON THE MARKET ARE BECOMING MORE PRECISE DUE IN PART TO ADVANCEMENTS IN DNA RESEARCH. HOW DO YOU THINK THE INCREASE OF MORE EFFECTIVE MEDICATIONS WILL IMPACT LITIGATION? 

Positively. Improvements in life sciences products will expand efficacy and reduce risk in their use. This will have positive effects in public health and secondarily likely reduce the extent of life sciences-related litigation.

AS THIRD-PARTY FUNDING BECOMES MORE OF AN INDUSTRY NORM, WHAT EFFECTS DO YOU THINK THIS WILL HAVE ON THE LIFE SCIENCES SECTOR? 

Extensive. Funding will result in more litigation generally, and more spurious claims in particular. Sooner rather than later, funders will be subject to certain disclosure and oversight regulation, which could bring greater transparency to this opaque and mysterious market. 

WHAT IS THE GREATEST CHALLENGE CURRENTLY FACING PRACTITIONERS IN THE LIFE SCIENCES SECTOR? 

Relevance. All lawyers, regardless of sector, must strive to stay relevant and valuable to their clients. This is especially true with the advent of legal AI and other technologies that make delivery of legal services more efficient for clients.

THERE HAS BEEN A NOTABLE RISE IN THE NUMBER OF CONSOLIDATED PROCEEDINGS IN THE US. HAS THIS AFFECTED YOUR PRACTICE? 

Definitely. Federal multi-district litigations and consolidated state proceedings have trended up significantly for the past several years. I’ve been privileged to lead trial and coordination efforts in defence of these types of proceedings for numerous clients.

HOW DO YOU PLAN TO DEVELOP YOUR PRACTICE IN THE FUTURE? 

Globally. As the global economy becomes more interconnected, I expect my experience managing and eliminating risk for clients will continue to evolve to meet the needs of domestic-based and foreign-based clients. This is particularly true for Asian clients with less experience with US-style litigation.

Practice Areas:

Follow us on LinkedIn

Practice Areas

Firms

Browse Firms

Search Firms

The Who's Who Legal 100

Awards

News & Features

Special Reports

Events

Shop

About Us

It is not possible to buy entry into any Who's Who Legal publication

Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.

Copyright © 2017 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 20 7908 1180 / Fax: +44 207 229 6910

http://www.whoswholegal.com | editorial@whoswholegal.com

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK